1. The following substances and products:| (1) | Acetorphine | | (2) | Acetylmethadol (also known as methadyl acetate) | | (3) | Allylprodine | | (4) | Alphacetylmethadol | | (5) | Alphameprodine | | (6) | Alphamethadol | | (7) | Alphaprodine | | (8) | [Deleted by S 194/2017] | | (9) | Amphetamine | | (10) | Anileridine | | (11) | Benzethidine | | (12) | Benzylmorphine (3-benzylmorphine) | | (13) | 1-Benzylpiperazine (also known as BZP) | | (14) | Betacetylmethadol | | (15) | Betameprodine | | (16) | Betamethadol | | (17) | Betaprodine | | (18) | Bezitramide | | (19) | 1‑(4‑Bromo‑2,5‑dimethoxyphenyl)propan‑2‑amine (also known as 4‑Bromo‑2,5‑dimethoxy‑α‑methylphenethylamine, 4-Bromo-2,5-dimethoxyamphetamine, Brolamfetamine or DOB) and its bromo and dimethoxy positional isomers in the phenyl ring | | (20) | 2-(4-Bromo-2,5-dimethoxyphenyl)ethanamine (also known as 4‑bromo-2,5-dimethoxyphenethylamine or 2C-B) and its bromo and dimethoxy positional isomers in the phenyl ring | | (21) | [Deleted by S 200/2016] | | (22) | Buprenorphine | | (23) | Cannabinol | | (24) | Cannabinol derivatives | | (25) | Cannabis and cannabis resin | | (26) | Cathinone | | (27) | Clonitazene | | (28) | Coca leaf | | (29) | Cocaine | | (30) | Codoxime | | (31) | 4-Cyano-2-dimethylamino-4,4-diphenylbutane | | (32) | 4-Cyano-1-methyl-4-phenyl-piperidine | | (33) | Desomorphine | | (34) | Dextromoramide | | (34A) | (2S)-2,6-Diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide (also known as Lisdexamphetamine or Lisdexamfetamine) and its stereoisomers | | (35) | Diamorphine | | (36) | Diampromide | | (36A) | N,N-Diethyl-3-hydroxy-7-methyl-2-oxo-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide (also known as 2‑Oxo-3-hydroxy-LSD) and its acyclic secondary and tertiary amide structural isomers | | (37) | Diethylthiambutene | | (38) | [Deleted by S 200/2016] | | (39) | Difenoxin | | (40) | Dihydroetorphine | | (41) | Dihydromorphine | | (42) | Dimenoxadole | | (43) | Dimepheptanol | | (44) | 1-(2,5-Dimethoxy-4-methylphenyl)propan-2-amine (also known as 2,5-Dimethoxy-4,α-dimethylphenethylamine, 2-Amino-1-(2,5-dimethoxy-4-methyl)phenylpropane or DOM) and its methyl and dimethoxy positional isomers in the phenyl ring | | (45) | 2,5-Dimethoxy-α-methylphenethylamine (also known as 2,5‑Dimethoxyamphetamine or DMA) and its dimethoxy positional isomers in the phenyl ring | | (46) | N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine (also known as 3,4-Methylenedioxymethamphetamine or MDMA) and its acyloxy or sulphonyl derivatives at the nitrogen atom, and the following example of such a derivative:| (a) | tert-Butyl N-[1-(1,3-benzodioxol-5-yl)propan-2-yl]-N-methylcarbamate (also known as N-tert-Butoxycarbonyl-MDMA or t-Boc-MDMA) |
| | (47) | 3-(1,2-Dimethylhepty1)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (also known as DMHP) | | (48) | Dimethylthiambutene | | (49) | [Deleted by S 200/2016] | | (50) | Dioxaphetyl butyrate | | (51) | Diphenoxylate | | (52) | Dipipanone | | (53) | Drotebanol | | (54) | Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine | | (55) | 4-Ethyl-2,5-dimethoxy-α-methylphenethylamine (also known as DOET) | | (56) | N-Ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine (also known as MDEA) | | (57) | Ethylmethylthiambutene | | (58) | Eticyclidine | | (59) | Etonitazene | | (60) | Etorphine | | (61) | Etoxeridine | | (62) | [Deleted by S 200/2016] | | (63) | Furethidine | | (64) | Gamma hydroxybutyric acid | | (65) | Hydrocodone | | (66) | Hydromorphinol | | (67) | Hydromorphone | | (68) | 1-Hydroxy-3-pentyl-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6-H-dibenzo[b,d]pyran | | (69) | Hydroxypethidine | | (70) | Isomethadone | | (71) | Ketamine and its acyloxy or sulphonyl derivatives at the nitrogen atom, and the following example of such a derivative:| (a) | tert-Butyl N-methyl-N-((2-chlorophenyl)-1-oxocyclohexan-2-yl)carbamate (also known as N-tert-Butoxycarbonyl-ketamine or t-Boc-ketamine) |
| | (72) | Ketobemidone | | (73) | Levomethorphan | | (74) | Levomoramide | | (75) | Levophenacylmorphan | | (76) | Levorphanol | | (77) | Lysergamide | | (78) | Lysergide and other compounds structurally derived from lysergamide by substitution of any of the hydrogen atoms, and the following examples of such a compound:| (a) | 1-Acetyl-N,N-diethyllysergamide (also known as N‑acetyl‑LSD or ALD-52) | | (b) | 6-Allyl-6-nor-lysergic acid diethylamide (also known as N‑allyl‑nor-LSD or AL-LAD) | | (c) | 6-Ethyl-6-nor-lysergic acid diethylamide (also known as ETH‑LAD) | | (d) | 6-Propyl-6-nor-lysergic acid diethylamide (also known as PRO‑LAD) | | (e) | Lysergic acid 2,4-dimethylazetidide (also known as LSZ) | | (f) | 1-Propionyl-N,N-diethyllysergamide (also known as 1‑Propionyl‑LSD or 1P-LSD) | | (g) | 1-Butanoyl-N,N-diethyllysergamide (also known as 1‑Butanoyl‑LSD or 1B-LSD) | | (h) | 1-Cyclopropionyl-N,N-diethyllysergamide (also known as 1‑Cyclopropionyl-LSD or 1cP‑LSD) |
| | (79) | Mescaline | | (80) | Metazocine | | (81) | Methadone | | (82) | [Deleted by S 284/2021] | | (83) | Methamphetamine (also known as Methylamphetamine) and its acyloxy or sulphonyl derivatives at the nitrogen atom, and the following examples of such a derivative:| (a) | tert-Butyl N-methyl-N-(1-phenylpropan-2-yl)carbamate (also known as N-tert-Butoxycarbonyl-methamphetamine or t‑Boc‑methamphetamine) | | (b) | N,4-Dimethyl-N-(3-phenyl-propan-2-yl)benzenesulfonamide (also known as N-Tosyl-methamphetamine) |
| | (84) | [Deleted by S 200/2016] | | (85) | 3-Methoxy-α-methyl-4,5-(methylenedioxy)phenethylamine (also known as 5-methoxy-MDA or MMDA) | | (86) | p-Methoxy-α-methylphenethylamine (also known as 4‑methoxyamphetamine or para-methoxyamphetamine) and its methoxy positional isomers in the phenyl ring | | (87) | N-Methyl-α-ethyl-3,4-(methylenedioxy)phenethylamine (also known as MBDB) | | (88) | N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine (also known as N-Hydroxy MDA) | | (89) | α-Methyl-3,4-(methylenedioxy)phenethylamine (also known as Tenamfetamine or MDA) | | (90) | 2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid | | (91) | 1-Methyl-4-phenylpiperidine-4-carboxylic acid | | (92) | 4-Methylaminorex | | (93) | Methyldesorphine | | (94) | Methyldihydromorphine (6-Methyldihydromorphine) | | (95) | 4-Methylthioamphetamine | | (96) | [Deleted by S 233/2018] | | (97) | Metopon | | (98) | Monoacetylmorphine | | (99) | Morpheridine | | (100) | Morphine | | (101) | Morphine methobromide, morphine N-oxide and other pentavalent nitrogen morphine derivatives | | (102) | Myrophine | | (103) | Nicomorphine (3,6-dinicotinoyl-morphine) | | (104) | Noracymethadol | | (105) | Norbuprenorphine | | (106) | Norketamine and its dehydro derivatives | | (107) | Norlevorphanol | | (108) | Normethadone | | (109) | Normorphine | | (110) | Norpipanone | | (111) | Opium | | (112) | Oxycodone | | (113) | Oxymorphone | | (114) | Parahexyl (3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran) | | (115) | Pethidine | | (116) | Phenadoxone | | (117) | Phenampromide | | (118) | Phenazocine | | (119) | Phenomorphan | | (120) | Phenoperidine | | (120A) | 4-Phenyl-N-(2-phenylethyl)piperidin-4-yl acetate (also known as 1‑Phenethyl-4-phenyl-4-piperidinol acetate or PEPAP) | | (121) | 4-Phenylpiperidine-4-carboxylic acid ethyl ester | | (122) | Piminodine | | (123) | Piritramide | | (124) | Poppy-straw and concentrate of poppy-straw | | (125) | Proheptazine | | (126) | Properidine (1-Methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester) | | (127) | [Deleted by S 200/2016] | | (128) | Psilocybine | | (129) | Racemethorphan | | (130) | Racemoramide | | (131) | Racemorphan | | (132) | [Deleted by S 233/2018] | | (133) | Rolicyclidine | | (133A) | Tapentadol | | (134) | Tenocyclidine | | (134A) | 6,7,8,14-Tetradehydro-4,5-α-epoxy-6-methoxy-17-methylmorphinan-3-ol (also known as 3-O-demethylthebaine or Oripavine) | | (135) | Thebacon | | (136) | Thebaine | | (137) | Tilidine | | (138) | 1-(3-Trifluoromethylphenyl)piperazine (also known as TFMPP) | | (139) | Trimeperidine | | (140) | [Deleted by S 284/2021] |
|
| 2. Any stereoisomeric form of a substance for the time being specified in paragraph 1, not being dextromethorphan or dextrorphan. |
| 3. Any ester or ether of a substance for the time being specified in paragraph 1 or 2, not being a substance for the time being specified in Part 2. |
| 4. Any salt of a substance for the time being specified in any of paragraphs 1, 2 and 3. |
| 5. Any preparation or other products containing a substance or product for the time being specified in any of paragraphs 1 to 4. |
| 6. Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1, 2 and 3 of Part 2. |
7. Fentanyl and any compounds structurally derived from N-(1-Methyl-4-piperidyl)-N-phenyl formamide by substitution of any of the hydrogen atoms, including the following; and any salt of any substance falling within this item:| (1) | Acetylfentanyl (also known as desmethyl fentanyl) | | (1AA) | Acryloylfentanyl (also known as Acrylfentanyl) | | (1A) | Alfentanil | | (2) | Alpha-methyl fentanyl | | (3) | Alpha-methyl fentanyl acetanilide | | (4) | Alpha-methylthiofentanyl | | (5) | Benzyl fentanyl | | (6) | Beta-hydroxy fentanyl | | (7) | Beta-hydroxy-3-methyl fentanyl | | (7A) | Butyryl fentanyl (also known as butyrfentanyl) | | (8) | Carfentanil | | (8AAA) | Crotonylfentanyl | | (8AA) | Cyclopropylfentanyl | | (8AB) | 4-Fluorobutyrfentanyl (also known as para-Fluoro-butyrfentanyl or p‑Fluoro-butyrfentanyl) | | (8AC) | 2-Fluorofentanyl (also known as ortho-Fluorofentanyl) | | (8AD) | 3-Fluorofentanyl (also known as meta-Fluorofentanyl) | | (8AE) | 4-Fluorofentanyl (also known as para-Fluorofentanyl) | | (8A) | 4-Fluoroisobutyrfentanyl (also known as 4-FIBF or pFIBF) | | (8B) | Furanyl fentanyl | | (9) | Lofentanil | | (9A) | Methoxyacetylfentanyl | | (9B) | 4-Methoxybutyrfentanyl (also known as para-Methoxy-butyrfentanyl or p-Methoxy-butyrylfentanyl) | | (10) | 3-Methyl fentanyl | | (10A) | 3-Methylthiofentanyl | | (10B) | Ocfentanil | | (11) | [Deleted by S 354/2019] | | (11A) | Remifentanil | | (12) | Sufentanil | | (12AA) | Tetrahydrofuranyl fentanyl (also known as THF-F) | | (12A) | Thiafentanil | | (13) | Thiofentanyl | | (14) | Valerylfentanyl |
|
| 8. [Deleted by S 751/2020] |
9. Any compound containing a 3-(1-naphthylmethyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2‑(4‑morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:| (1) | 3-[(4-Methylnaphthalen-1-yl)methyl]-1-pentyl-1H-indole (also known as JWH-184) | | (2) | 3-(Naphthalen-1-ylmethyl)-1-pentyl-1H-indole (also known as JWH‑175) |
|
10. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2‑(4‑morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:| (1) | [5-(2-Chlorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-369) | | (2) | [5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-307) | | (3) | [5-(3-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-368) | | (4) | (1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-147) | | (5) | (1-Hexyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-031) | | (6) | [5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-370) | | (7) | Naphthalen-1-yl[5-(naphthalen-1-yl)-1-pentyl-1H-pyrrol-3-yl]methanone (also known as JWH-309) | | (8) | Naphthalen-1-yl(1-pentyl-5-phenyl-1H-pyrrol-3-yl)methanone (also known as JWH-145) | | (9) | Naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone (also known as JWH-030) |
|
11. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2‑(4‑morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:| (1) | E-1-[1-(1-Naphthalenylmethylene)-1H-inden-3-yl]pentane (also known as JWH-176) |
|
| 12. [Deleted by S 751/2020] |
13. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2‑(4‑morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not substituted in the cyclohexyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:| (1) | 2-[5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol (also known as CP55,940) | | (2) | 2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol (also known as CP47,497) |
|
| 14. [Deleted by S 751/2020] |
| 15. [Deleted by S 751/2020] |
16. Any compound, other than bupropion, that is structurally derived from 2‑amino-1-phenylpropan-1-one by modification in any of the following ways:| (a) | substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents; | | (b) | substitution at the 3-position with an alkyl substituent; | | (c) | substitution at the nitrogen atom with alkyl, cycloalkyl or dialkyl, benzyl or methoxybenzyl groups, or by inclusion of the nitrogen atom in a cyclic structure, [S 453/2023 wef 01/07/2023] |
| including any salt or stereoisomeric form of the above compounds, and any preparation or product containing the above compounds, for example: |
| (1) | 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)propan-1-one (also known as 3,4-Methylenedioxy-N-benzylcathinone or BMDP) | | (1AAA) | 1-(1,3-Benzodioxol-5-yl)-2-(cyclohexylamino)propan-1-one (also known as 3,4-methylenedioxy-N-cyclohexylcathinone or 3,4-methylenedioxy-α-cyclohexylaminopropiophenone or N-cyclohexylmethylone or Cyputylone) [S 453/2023 wef 01/07/2023] | | (1AA) | 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-butanone (also known as Dibutylone or bk-DMBDB) | | (1A) | 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-propanone (also known as bk-MDDMA) | | (1BA) | 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (also known as N,N-dimethylpentylone, dipentylone or bk-DMBDP) [S 453/2023 wef 01/07/2023] | | (1B) | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)-1-butanone (also known as Eutylone) | | (1C) | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one (also known as 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one) or N‑Ethylpentylone or N-Ethylnorpentylone or Ephylone) | | (2) | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one (also known as ethylone or 3,4-Methylenedioxy-N-ethylcathinone or bk-MDEA or MDEC) | | (3) | 1-(1,3-Benzodioxol-5-yl)-2-(methylamino)butan-1-one (also known as butylone) | | (4) | 1-(1,3-Benzodioxol-5-yl)-2-(methylamino)pentan-1-one (also known as pentylone) | | (5) | 1-(1,3-Benzodioxol-5-yl)-2-(methylamino)propan-1-one (also known as methylone or 3,4-methylenedioxy-N-methylcathinone) | | (6) | 1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one (also known as MDPBP) | | (6A) | 1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one (also known as 3,4-Methylenedioxy-α-pyrrolidinohexanophenone or 3,4-MDPHP) [S 440/2022 wef 01/06/2022] | | (7) | 1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as 3,4-methylenedioxypyrovalerone or MDPV) | | (8) | 1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-one (also known as MDPPP) | | (8A) | 2-(Benzylamino)-1-(4-methylphenyl)propan-1-one (also known as Benzedrone) | | (8AAA) | 1-(4-Bromophenyl)-2-(ethylamino)propan-1-one (also known as 4‑Bromoethcathinone or 4-BEC) | | (8AA) | 1-(4-Bromophenyl)-2-(methylamino)propan-1-one (also known as 4‑Bromomethcathinone or Brephedrone or 4-BMC) | | (8AAAA) | 2-(Butylamino)-1-phenylhexan-1-one (also known as N-Butylhexedrone or α-Butylaminohexanophenone) [S 440/2022 wef 01/06/2022] | | (8AAB) | 1-(4-Chlorophenyl)-2-(dimethylamino)propan-1-one (also known as 4‑Chloro-N,N-dimethylcathinone) | | (8AB) | 1-(4-Chlorophenyl)-2-(ethylamino)propan-1-one (also known as 4‑Chloroethcathinone or 4-CEC) | | (8B) | 1-(4-Chlorophenyl)-2-(methylamino)propan-1-one (also known as 4‑Chloromethcathinone or Clephedrone or 4-CMC) | | (8C) | 2-(Diethylamino)-1-phenyl-1-propanone (also known as amfepramone or diethylpropion or diethylcathinone) | | (9) | 2-(Dimethylamino)-1-phenylpropan-1-one (also known as metamfepramone or dimethylcathinone) | | (10) | 1-(3,4-Dimethylphenyl)-2-(methylamino)propan-1-one (also known as 3,4-Dimethylmethcathinone or 3,4-DMMC) | | (10A) | 2-(Ethylamino)-1-(4-ethylphenyl)propan-1-one (also known as 4‑Ethylethcathinone) | | (10B) | 2-(Ethylamino)-1-(4-fluorophenyl)propan-1-one (also known as 4‑Fluoroethcathinone or 4-FEC) | | (10C) | 2-(Ethylamino)-1-(4-methylphenyl)pentan-1-one (also known as 4‑Methyl-α-ethylaminopentiophenone or 4-MEAPP) | | (11) | 2-(Ethylamino)-1-(4-methylphenyl)propan-1-one (also known as 4‑Methylethcathinone or 4-MEC) | | (12) | 2-(Ethylamino)-1-phenylbutan-1-one (also known as N‑ethylbuphedrone) | | (12A) | 2-(Ethylamino)-1-phenylhexan-1-one (also known as N‑Ethylhexedrone or Ethyl-hexedrone) | | (13) | 2-(Ethylamino)-1-phenylpentan-1-one (also known as α‑Ethylaminopentiophenone or N-Ethylpentedrone) | | (14) | 2-(Ethylamino)-1-phenylpropan-1-one (also known as ethcathinone) | | (14A) | 1-(4-Ethylphenyl)-2-(methylamino)propan-1-one (also known as 4‑Ethylmethcathinone or 4-EMC) | | (14B) | 1-(4-Fluoro-3-methylphenyl)-2-(pyrrolidin-1-yl)pentan‑1‑one (also known as 4‑Fluoro‑3‑methyl‑α‑pyrrolidinopentiophenone or 4‑Fluoro‑3‑methyl‑α‑PVP) | | (15) | 1-(4-Fluorophenyl)-2-(methylamino)propan-1-one (also known as 4‑Fluoromethcathinone or Flephedrone or 4-FMC) | | (15AA) | 1-(4-Fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one (also known as 4‑Fluoro-PHP) | | (15A) | 1-(4-Fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as 4‑Fluoro-α-PVP) | | (16) | 1-(4-Methoxyphenyl)-2-(methylamino)propan-1-one (also known as 4‑Methoxymethcathinone or Methedrone or bk-PMMA or PMMC) | | (17) | 1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)propan-1-one (also known as MOPPP) | | (17AA) | 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (also known as α-PiHP or α-pyrrolidinoisohexanophenone) [S 453/2023 wef 01/07/2023] | | (17A) | 2-(Methylamino)-1-(4-methylphenyl)butan-1-one (also known as 4‑Methylbuphedrone or 4-Me-MABP) | | (18) | 2-(Methylamino)-1-phenylbutan-1-one (also known as buphedrone) | | (19) | 2-(Methylamino)-1-phenylpentan-1-one (also known as pentedrone or α-Methylaminovalerophenone) | | (20) | 2-(Methylamino)-1-phenylpropan-1-one (also known as methcathinone) | | (20A) | 1-(3-Methylphenyl)-2-(methylamino)propan-1-one (also known as 3-methylmethcathinone, metaphedrone or 3-MMC) [S 453/2023 wef 01/07/2023] | | (21) | 1-(4-Methylphenyl)-2-(methylamino)propan-1-one (also known as 4‑Methylmethcathinone or Mephedrone or 4-MMC) | | (22) | 1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)butan-1-one (also known as MPBP) | | (22A) | 1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one (also known as 4‑Methyl-α-pyrrolidinohexanophenone or MPHP) | | (23) | 1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as pyrovalerone) | | (23A) | 1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)propan-1-one (also known as 4‑Methyl-α-pyrrolidinopropiophenone or 4-MePPP) | | (24) | 1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one (also known as α-PBP) | | (24A) | 1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one (also known as Alpha‑Pyrrolidinohexiophenone or Alpha-PHP or α-PHP) | | (25) | 1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one (also known as α-PVP) | | (26) | 1-Phenyl-2-(pyrrolidin-1-yl)propan-1-one (also known as α-PPP) |
|
17. Any compound that is structurally derived from 2-aminopropan-1-one by substitution at the 1-position with any monocyclic, or fused-polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the compound is further modified in any of the following ways:| (a) | substitution in the ring system to any extent with alkyl, alkoxy, haloalkyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; | | (b) | substitution at the 3-position with an alkyl substituent; or | | (c) | substitution at the 2-amino nitrogen atom with alkyl, cycloalkyl or dialkyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure, [S 453/2023 wef 01/07/2023] |
| including any salt or stereoisomeric form of the above compounds, and any preparation or product containing the above compounds, for example: |
| (1) | 1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as naphyrone or naphthylpyrovalerone) | | (2) | 2-(Pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one (also known as α‑Pyrrolidinopentiothiophenone or α-PVT) |
|
18. The following compounds, including any salt or stereoisomeric form of such compounds, and any preparation or product containing such compounds:| (1) | 2-Amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one (also known as bk-2C-B) and its bromo and dimethoxy positional isomers in the phenyl ring | | (1A) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1H-indazole-3-carboxamide (also known as ADB-5-Bromo-INACA) and its N-(1-amino-1-oxohexan-2-yl) isomers and their respective bromo positional isomers in the 6-membered ring of the indazole structure [S 440/2022 wef 01/06/2022] [S 453/2023 wef 01/07/2023] | | (2) | 4-(2-Aminopropyl)benzofuran (also known as 4-APB) | | (3) | 5-(2-Aminopropyl)benzofuran (also known as 5-APB) | | (4) | 6-(2-Aminopropyl)benzofuran (also known as 6-APB or BenzoFury) | | (5) | 7-(2-Aminopropyl)benzofuran (also known as 7-APB) | | (6) | 4-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 4-APDB) | | (7) | 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 5-APDB) | | (8) | 6-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 6-APDB) | | (9) | 7-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 7-APDB) | | (10) | 1-(1-Benzofuran-5-yl)-N-ethylpropan-2-amine (also known as 5‑EAPB) and its 4-yl, 6-yl and 7-yl isomers | | (11) | 1-Benzyl-4-methylpiperazine (also known as Methylbenzylpiperazine or MBZP) | | (12) | 2-Bis(4-fluorophenyl)methylsulfinyl-N-methylacetamide (also known as N-Methyl-4,4-difluoromodafinil or modafiendz) and its fluoro positional isomers in the phenyl rings | | (13) | 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25B-NBOMe) and its bromo, dimethoxy and methoxy positional isomers in the respective phenyl rings | | (14) | 2-N-[2-(4-Bromo-2,5-dimethoxyphenylethyl)aminomethyl]phenol (also known as 25B-NBOH) and its bromo, dimethoxy and hydroxy positional isomers in the respective phenyl rings | | (15) | 4-Bromo-N-[2-(dimethylamino)cyclohexyl]‑benzamide (also known as Bromadoline or U‑47931E) and its bromo positional isomers in the phenyl ring and diamino positional isomers in the cyclohexyl ring | | (16) | 4-Bromo-N-[2-(dimethylamino)cyclohexyl]-N-methyl-benzamide (also known as N‑Methyl U‑47931E or N‑Methyl Bromadoline) and its bromo positional isomers in the phenyl ring and diamino positional isomers in the cyclohexyl ring | | (16A) | 1-(1-(1-(4-Bromophenyl)ethyl)-piperidin-4-yl)-1,3-dihydro-2H-imidazol-2-one (also known as Brorphine) and its bromo positional isomers in the phenyl ring [S 440/2022 wef 01/06/2022] | | (16B) | 2-(2-(4-Butoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine (also known as butonitazene or butoxynitazene) and its diethylamino and butoxy structural isomers and their respective butoxy positional isomers in the phenyl ring and nitro positional isomers in the 6-membered ring of the benzimidazole structure [S 453/2023 wef 01/07/2023] | | (17) | 17-Carboxy-16,17-dihydromitragynine | | (18) | 16-Carboxymitragynine | | (19) | 1-(4-Chloro-2,5-dimethoxyphenyl)propan-2-amine (also known as 4‑Chloro-2,5-dimethoxy-α-methylphenethylamine, 4‑Chloro‑2,5‑dimethoxyamphetamine, DOC, 3C‑C, 4‑Cl‑2,5‑DMA or 4‑Chloro-2,5-DMA) and its chloro and dimethoxy positional isomers in the phenyl ring | | (20) | 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine also known as 2C‑C) and its chloro and dimethoxy positional isomers in the phenyl ring | | (21) | 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25C-NBOMe) and its chloro, dimethoxy and methoxy positional isomers in the respective phenyl rings | | (22) | 2-N-[2-(4-Chloro-2,5-dimethoxyphenylethyl)aminomethyl]phenol (also known as 25C-NBOH) and its chloro, dimethoxy and hydroxy positional isomers in the respective phenyl rings | | (22A) | 5-(Cyclobutylmethyl)-2-(2-phenylpropan-2-yl)-pyrido[4,3-b]indol-1-one (also known as Cumyl-CB-MeGACLONE, Cumyl-CBMGACLONE, cumyl-cyclobutylmethyl-gammacarbolinone or SGT-273) and its phenylpropyl isomers [S 453/2023 wef 01/07/2023] | | (23) | 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (also known as MT-45) | | (23A) | 2-(1-(Cyclohexylmethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-(Cyclohexylmethyl)-2-oxoindolin-3-ylidene)benzohydrazide or BZO-CHMOXIZID) [S 440/2022 wef 01/06/2022] | | (23AA) | N-Cyclohexyl-2-(1-(4-hydroxypentyl)-1H-indol-3-yl)acetamide and its hydroxy positional isomers in the pentyl group [S 453/2023 wef 01/07/2023] | | (23AB) | N-Cyclohexyl-2-(1-pentyl-1H-indol-3-yl)acetamide (also known as CH-PIATA) [S 453/2023 wef 01/07/2023] | | (24) | 17-O-Desmethyl-16,17-dihydromitragynine | | (25) | 9-O-Desmethylmitragynine | | (26) | 3,4-Dibromo-N-methyl-N-(1-methyl-1-azaspiro[4.5]decan-6-yl)benzamide (also known as U‑77891) and its dibromo positional isomers in the phenyl ring and their respective azaspiro[4.5]decanyl isomers | | (27) | 3,4-Dichloromethylphenidate and its dichloro positional isomers in the phenyl ring (also known as 3,4-DCMP) | | (28) | 3,4-Dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (also known as AH-7921) and its dichloro positional isomers in the phenyl ring | | (29) | 3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (also known as U-47700) and its dichloro positional isomers in the phenyl ring and diamino positional isomers in the cyclohexyl ring | | (30) | N,N-Diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine (also known as Isotonitazene) and its diethylamino structural isomers and their respective isopropoxy positional isomers in the phenyl ring and nitro positional isomers in the 6‑membered ring of the benzimidazole structure | | (30A) | N,N-Diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine (also known as Metonitazene) and its diethylamino structural isomers and their respective methoxy positional isomers in the phenyl ring and nitro positional isomers in the 6-membered ring of the benzimidazole structure [S 440/2022 wef 01/06/2022] | | (30B) | N,N-Diethyl-2-(2-(4-propoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine (also known as protonitazene or propoxynitazene) and its diethylamino structural isomers and their respective propoxy positional isomers in the phenyl ring and nitro positional isomers in the 6-membered ring of the benzimidazole structure [S 453/2023 wef 01/07/2023] | | (31) | 2,3-Dihydro-1H-inden-2-amine (also known as 2-Aminoindane) | | (32) | 6,7-Dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (also known as 5,6-(methylenedioxy)-2-aminoindane or MDAI) | | (33) | 2,3-Dihydro-5-iodo-1H-inden-2-amine (also known as 5‑Iodo‑2‑aminoindane or 5-IAI) | | (34) | [2,3-Dihydro-5-methyl-3-(morpholin-4-ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl](naphthalen-1-yl)methanone | | (35) | {4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-bicyclo[3.1.1]hept-2-en-2-yl}methanol | | (36) | 2-(2,5-Dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25H-NBOMe) and its dimethoxy and methoxy positional isomers in the respective phenyl rings | | (37) | 2-(2,5-Dimethoxyphenyl)ethanamine (also known as 2C-H) and its dimethoxy positional isomers in the phenyl ring | | (38) | 2-N-[2-(2,5-Dimethoxyphenylethyl)aminomethyl]phenol (also known as 25H-NBOH) and its dimethoxy and hydroxy positional isomers in the respective phenyl rings | | (39) | 6,6-Dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1,9-diol | | (40) | N,N-Dimethyl-1-phenylpropan-2-amine (also known as N,N‑dimethylamphetamine) | | (41) | Diphenyl(pyrrolidin-2-yl)methanol (also known as diphenylprolinol) | | (42) | 1-(1,2-Diphenylethyl)piperidine (also known as Diphenidine) | | (43) | 2-Diphenylmethylpiperidine (also known as desoxypipradrol) | | (43AA) | 2-(2-(4-Ethoxybenzyl)-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine (also known as etodesnitazene, etazene, etazen, etazone or desnitroetonitazene) and its diethylamino structural isomers and their respective ethoxy positional isomers in the phenyl ring [S 453/2023 wef 01/07/2023] | | (43AB) | 2-(4-Ethoxybenzyl)-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H-benzimidazole (also known as etonitazepyne or N-pyrrolidino etonitazene) and its ethoxy positional isomers in the phenyl ring and their respective nitro positional isomers in the 6-membered ring of the benzimidazole structure [S 453/2023 wef 01/07/2023] | | (43A) | N-Ethyl-1-(3-fluorophenyl)propan-2-amine (also known as 3-Fluoroethamphetamine, 3-Fluoroethylamphetamine or 3-FEA) and its fluoro positional isomers in the phenyl ring [S 440/2022 wef 01/06/2022] | | (44) | 2-(Ethylamino)-2-phenyl-cyclohexan-1-one (also known as Deschloro‑N-ethyl-ketamine) | | (45) | Ethylphenidate | | (45A) | 2-(2-(1-(4-Fluorobenzyl)-1H-(6-hydroxyindol)-3-yl)acetamido)-3,3-dimethylbutanamide and its N-(1-amino-1-oxohexan-2-yl) isomers and their respective fluoro positional isomers in the phenyl ring and hydroxy positional isomers in the 6-membered ring of the indole structure [S 440/2022 wef 01/06/2022] | | (45B) | 2-(2-(1-(4-Fluorobenzyl)-1H-indol-3-yl)acetamido)-3,3-dimethylbutanamide (also known as ADB-FUBIATA or FUB-ACADB or AD-18) and its N-(1-amino-1-oxohexan-2-yl) isomers and their respective fluoro positional isomers in the phenyl ring [S 440/2022 wef 01/06/2022] | | (46) | 2-Fluorodeschloroketamine (also known as 2-Fluoroketamine or 2‑FDCK) and its fluoro positional isomers in the phenyl ring | | (47) | 4-Fluoromethylphenidate and its fluoro positional isomers in the phenyl ring | | (47A) | 2-(1-(5-Fluoropentyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-(5-Fluoropentyl)-2-oxoindolin-3-ylidene)benzohydrazide or 5-Fluoro-BZO-POXIZID or 5F-BZO-POXIZID or MDA-19 5-fluoropentyl analogue or 5F-MDA-19) and its fluoro positional isomers in the pentyl group [S 440/2022 wef 01/06/2022] | | (48) | 5-(5-Fluoropentyl)-2-(2-phenylpropan-2-yl)-pyrido[4,3-b]indol-1-one (also known as 2-Cumyl-5-(5-fluoropentyl)-gamma-carbolin-1-one or 5-Fluoro-cumyl-PEGACLONE) and its phenylpropyl isomers and their respective fluoro positional isomers in the pentyl group | | (49) | 2-(3-Fluorophenyl)-3-methylmorpholine (also known as 3‑Fluorophenmetrazine or 3F‑phenmetrazine) and its fluoro positional isomers in the phenyl ring | | (50) | 1-(4-Fluorophenyl)piperazine (also known as 4‑Fluorophenylpiperazine or 4-FPP) and its fluoro positional isomers in the phenyl ring | | (51) | 1-(4-Fluorophenyl)propan-2-amine (also known as 4‑Fluoroamphetamine or 4-FA) and its fluoro positional isomers in the phenyl ring | | (51A) | 2-(1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide or BZO-HEXOXIZID or MDA-19) [S 440/2022 wef 01/06/2022] | | (51B) | N’-(1-Hexyl-2-oxoindolin-3-ylidene)-4-hydroxybenzohydrazide and its hydroxy positional isomers in the phenyl ring [S 453/2023 wef 01/07/2023] | | (52) | 1-Hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6,6a,7,8,10,10a-hexahydro-9H-benzo[c]chromen-9-one | | (53) | [9-Hydroxy-6-methyl-3-(5-phenylpentan-2-yl)oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate | | (54) | 3-Hydroxy-2-[3-methyl-6-(2-propenyl)-cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone | | (54AA) | N’-(1-(4-Hydroxycyclohexylmethyl)-2-oxoindolin-3-ylidene)benzohydrazide and its hydroxy positional isomers in the cyclohexyl group [S 453/2023 wef 01/07/2023] | | (54A) | 2-(1-(5-Hydroxyhexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-(5-Hydroxyhexyl)-2-oxoindolin-3-ylidene)benzohydrazide) and its hydroxy positional isomers in the hexyl group [S 440/2022 wef 01/06/2022] | | (55) | 9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol (for example HU‑210, HU-211) | | (56) | 7-Hydroxymitragynine | | (56A) | 2-(1-(5-Hydroxypentyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-(5-Hydroxypentyl)-2-oxoindolin-3-ylidene)benzohydrazide) and its hydroxy positional isomers in the pentyl group [S 440/2022 wef 01/06/2022] | | (57) | 5-(5-Hydroxypentyl)-2-(2-phenylpropan-2-yl)-pyrido[4,3-b]indol-1-one and its phenylpropyl isomers and their respective hydroxy positional isomers in the pentyl group | | (58) | 1-(1H-Indol-5-yl)propan-2-amine (also known as 5-IT) and its 4-yl, 6‑yl and 7-yl isomers | | (59) | 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25I-NBOMe) and its dimethoxy, iodo and methoxy positional isomers in the respective phenyl rings | | (60) | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (also known as 2C-I) and its dimethoxy and iodo positional isomers in the phenyl ring | | (61) | 2-N-[2-(4-Iodo-2,5-dimethoxyphenylethyl)aminomethyl]phenol (also known as 25I-NBOH) and its dimethoxy, hydroxy and iodo positional isomers in the respective phenyl rings | | (62) | 3-Methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one (also known as Mexedrone) and its methyl positional isomers in the phenyl ring | | (63) | N-[1-(3-Methoxyphenyl)cyclohexyl]-piperidine (also known as 3‑Methoxyphencyclidine or 3-Methoxy-PCP or 3-MeO-PCP) and its methoxy positional isomers in the phenyl ring | | (64) | 2-(3-Methoxyphenyl)-2-(N-ethylamino)cyclohexanone (also known as methoxetamine) | | (65) | 1-[1-(2-Methoxyphenyl)-2-phenylethyl]piperidine (also known as 2‑MeO‑Diphenidine or 2‑MXP or methoxphenidine) and its methoxy positional isomers in the phenyl ring | | (66) | N-Methyl-5-(2-aminopropyl)benzofuran (also known as 5‑MAPB) and its 4‑yl, 6‑yl and 7‑yl isomers | | (67) | N-Methyl-1-(4-fluorophenyl)propan-2-amine (also known as 4‑Fluoromethamphetamine or 4-FMA) and its fluoro positional isomers in the phenyl ring | | (68) | N-Methyl-1-(4-methoxyphenyl)propan-2-amine (also known as 4‑Methoxymethamphetamine or para-Methoxymethamphetamine or PMMA) and its methoxy positional isomers in the phenyl ring | | (69) | 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine (also known as 4,4’-Dimethylaminorex, 4,4’‑DMAR or para‑methyl‑4‑methylaminorex) and its methyl positional isomers in the phenyl ring | | (70) | N-Methyl-1-(4-methylphenyl)propan-2-amine (also known as 4‑Methylmethamphetamine or 4-MMA) and its methyl positional isomers in the phenyl ring | | (70A) | 1-(2-Methyl-4-(3-phenyl-prop-2-en-1-yl)-piperazin-1-yl)-1-butanone (also known as 2-methyl-AP-237 or 2-methyl buccinazine) and its methyl positional isomers in the piperazinyl ring [S 453/2023 wef 01/07/2023] | | (71) | (N-Methyl-4-phenylpiperidin-4-yl)propanoate (also known as 1‑Methyl-4-phenyl-4-piperidinol propionate, desmethylprodine or MPPP) | | (72) | N-Methyl-1-(thiophen-2-yl)propan-2-amine (also known as methiopropamine) and its thiophen-3-yl isomer | | (73) | 1-(4-Methylbenzo-1,3-dioxol-6-yl)propan-2-amine (also known as 5‑methyl-MDA or 5-methyl-3,4-methylenedioxyamphetamine) | | (74) | Mitragynine | | (75) | Naphthalen-1-yl(4-pentyloxynaphthalen-1-yl)methanone (also known as CB-13) | | (75A) | 2-(1-Pentyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide (also known as N’-(1-Pentyl-2-oxoindolin-3-ylidene)benzohydrazide or BZO-POXIZID or MDA-19 pentyl analogue or 5C-MDA-19) [S 440/2022 wef 01/06/2022] | | (76) | 2-Phenyl-2-(methylamino)cyclohexanone (also known as Deschloroketamine) | | (76A) | 1-Phenyl-2-phenyl-2-(1-pyrrolidinyl)ethanone (also known as α-Pyrrolidino-2-phenylacetophenone or α-D2PV) [S 440/2022 wef 01/06/2022] | | (77) | 2-(2-Phenylpropan-2-yl)-5-pentyl-pyrido[4,3-b]indol-1-one (also known as 2-Cumyl-5-pentylgamma-carbolin-1-one or cumyl‑PEGACLONE or SGT-151) and its phenylpropyl isomers | | (78) | 5-[(2-Phenylpropan-2-yl)-pyrido[4,3-b]indol-1-one-yl]pentanoic acid and its phenylpropyl isomers | | (79) | Salvinorin A | | (80) | 2,4,5-Trimethoxy-α-methylphenethylamine (also known as 2,4,5‑Trimethoxyamphetamine or TMA‑2) and its trimethoxy positional isomers in the phenyl ring |
|
19. Any compound (other than serotonin) structurally derived from 2‑(1H‑indol-3-yl)ethanamine (also known as tryptamine) by modification in any of the following ways:| (a) | substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents, or by inclusion of only the nitrogen atom of the side chain in a cyclic structure; | | (b) | substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents; | | (c) | substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, hydroxy, thioalkyl, alkylenedioxy, halide or acetoxy substituents; | | (d) | substitution at the 2-position of the tryptamine ring system with an alkyl substituent, |
| including any ether, salt or stereoisomeric form of any such compound, any preparation or product containing any such compound, and the following examples of such a compound: |
| (1) | 4-Acetoxy-N,N-diisopropyltryptamine (also known as 4‑Acetoxy‑DiPT or 4-AcO-DiPT) | | (2) | 4-Acetoxy-N,N-dimethyltryptamine (also known as 4-Acetoxy-DMT or 4-AcO-DMT) | | (3) | 5-Benzyloxytryptamine | | (4) | 5-Bromo-N,N-dimethyltryptamine (also known as 5-Bromo-DMT) | | (5) | 5-Bromotryptamine | | (6) | 5-Chloro-α-methyltryptamine (also known as 5-Chloro-AMT) | | (7) | 5-Chlorotryptamine | | (8) | N,N-Diallyltryptamine | | (9) | N,N-Diethyltryptamine | | (10) | N,N-Diisopropyltryptamine | | (11) | N,N-Dimethyltryptamine | | (12) | N,N-Dipropyltryptamine | | (13) | Etryptamine | | (14) | 5-Fluoro-N,N-dimethyltryptamine (also known as 5-Fluoro-DMT) | | (15) | 5-Fluoro-α-methyltryptamine (also known as 5-Fluoro-AMT) | | (16) | 5-Fluorotryptamine | | (17) | 4-Hydroxy-N,N-diethyltryptamine (also known as 4-Hydroxy-DET or 4-HO-DET) | | (18) | 4-Hydroxy-N,N-diisopropyltryptamine (also known as 4‑Hydroxy‑DiPT or 4-HO-DiPT) | | (19) | 4-Hydroxy-N,N-dimethyltryptamine (also known as Psilocin) | | (20) | 4-Hydroxy-N-methyl-N-ethyltryptamine (also known as 4‑Hydroxy‑MET or 4-HO-MET) | | (21) | 4-Hydroxy-N-methyl-N-isopropyltryptamine (also known as 4‑Hydroxy-MiPT or 4-HO-MiPT) | | (22) | 4-Hydroxy-α-methyltryptamine (also known as 4-Hydroxy-AMT or 4‑HO-AMT) | | (23) | 5-Hydroxy-N-methyltryptamine (also known as 5-Hydroxy-NMT or 5‑HO-NMT) | | (24) | 5-Hydroxy-N,N-dimethyltryptamine (also known as Bufotenine) | | (25) | 5-Methoxy-N,N-diallyltryptamine (also known as 5-Methoxy-DALT or 5-MeO-DALT) | | (26) | 5-Methoxy-N,N-diethyltryptamine (also known as 5-Methoxy-DET or 5-MeO-DET) | | (27) | 5-Methoxy-N,N-diisopropyltryptamine (also known as 5‑Methoxy‑DiPT or 5-MeO-DiPT) | | (28) | 5-Methoxy-N,N-dimethyltryptamine (also known as 5-Methoxy-DMT or 5-MeO-DMT) | | (29) | 5-Methoxy-N,N-dipropyltryptamine (also known as 5-Methoxy-DPT or 5-MeO-DPT) | | (30) | 5-Methoxy-N-ethyl-N-isopropyltryptamine (also known as 5-Methoxy-EiPT or 5-MeO-EiPT) | | (31) | 5-Methoxy-N-ethyl-N-propyltryptamine (also known as 5-Methoxy-EPT or 5-MeO-EPT) | | (32) | 5-Methoxy-α-ethyltryptamine (also known as 5-Methoxy-AET or 5‑MeO-AET) | | (33) | 5-Methoxy-N-methyl-N-isopropyltryptamine (also known as 5‑Methoxy-MiPT or 5-MeO-MiPT) | | (34) | 5-Methoxy-α-methyltryptamine (also known as 5-Methoxy-AMT or 5‑MeO-AMT) | | (35) | 5-Methoxy-N-methyltryptamine (also known as 5-Methoxy-NMT or 5‑MeO-NMT) | | (36) | 4-Methyl-α-ethyltryptamine (also known as 4-Methyl-AET) | | (37) | 5-Methyltryptamine | | (38) | α-Methyltryptamine | | (39) | N-Methyltryptamine |
|
20. Any compound structurally derived from indole-3-carboxaldehyde or indole-2-carboxaldehyde by substitution —| (a) | at the nitrogen atom of the indole ring with a type A substituent; and | | (b) | at the hydrogen atom of the carboxaldehyde with a type B substituent, |
| whether or not the compound is further modified in any of the following ways: |
| (c) | substitution of the indole ring with a nitrogen heterocyclic analog; | | (d) | substitution to the indole ring or its nitrogen heterocyclic analog to any extent; | | (e) | substitution to the type B substituent to any extent, |
| including any salt or stereoisomeric form of the compound or derivative of the compound, any preparation or product containing the compound or derivative of the compound, and the following examples of such a compound or derivative: |
| (1) | [1-(5-Bromopent-1-yl)-1H-indazol-3-yl](naphthalene-1-yl)methanone (also known as 5-Bromo-THJ-018) | | (2) | [1-(5-Bromopent-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as 5-Bromo-UR-144) | | (3) | [1-(5-Chloropent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (also known as 5-Chloro-THJ-018) | | (4) | [1-(5-Chloropent-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as 5-Chloro-UR-144) | | (5) | [1-(4-Fluorobenzyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as FUB-144 or FUB‑UR-144) | | (6) | [1-(5-Fluoropent-1-yl)-1H-benzimidazol-2-yl](naphthalen-1-yl)methanone (also known as FUBIMINA) | | (7) | [1-(5-Fluoropent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (also known as THJ-2201) | | (8) | [1-(5-Fluoropent-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as XLR-11 or 5‑Fluoro-UR-144) | | (9) | [1-(5-Hydroxypent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone | | (10) | [1-(5-Hydroxypent-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | | (11) | [1-(5-Iodopent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (also known as 5-Iodo-THJ-018) | | (12) | Naphthalen-1-yl[1-(pent-1-yl)-1H-indazol-3-yl]methanone (also known as THJ-018) | | (13) | 5-[3-(1-Naphthoyl)-1H-indazol-1-yl]pentanoic acid | | (14) | 5-[3-(1-Naphthoyl)-1H-indol-1-yl]pentanenitrile (also known as AM‑2232) | | (15) | (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (also known as UR-144) | | (16) | 5-[3-(2,2,3,3-Tetramethylcyclopropanecarbonyl)-1H-indol-1-yl]pentanoic acid | | (17) | (1-Butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-073) | | (18) | (4-Chloronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-398) | | (19) | [1-(4-Chloropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as 4-Chloro-AM-2201) | | (20) | (4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-210) | | (21) | [1-(5-Fluoropent-1-yl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone (also known as MAM-2201) | | (22) | [1-(5-Fluoropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as AM-2201) | | (23) | [1-(4-Fluoropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as 4-Fluoro-AM-2201) | | (24) | [1-(5-Fluoropent-1-yl)-6-nitro-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as AM-1235) | | (25) | [1-(Heptan-2-yl)-2-methyl-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as JWH-011) | | (26) | (1-Heptyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-020) | | (27) | (1-Hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-019) | | (28) | (4-Methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-081) | | (29) | (2-Methyl-1-propyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-015) | | (30) | (4-Methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-122) | | (31) | {1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone (also known as AM-1220) | | (32) | {1-[2-(Morpholin-4-yl)ethyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone (also known as JWH-200) | | (33) | Naphthalen-1-yl[1-(pent-4-en-1-yl)-1H-indol-3-yl]methanone (also known as JWH-022) | | (34) | Naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-018) | | (35) | Naphthalen-1-yl(1-propyl-1H-indol-3-yl)methanone (also known as JWH-072) | | (36) | 2-(2-Chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-203) | | (37) | 1-[1-(2-Cyclohexylethyl)-1H-indol-3-yl]-2-(2-methoxyphenyl)ethanone (also known as RCS-8) | | (38) | 2-(2-Methoxyphenyl)-1-{1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}ethanone (also known as cannabipiperidiethanone) | | (39) | 2-(2-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-250) | | (40) | 2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-302) | | (41) | 2-(4-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-201) | | (42) | 2-(2-Methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-251) | | (43) | [1-(5-Fluoropentyl)-1H-indol-3-yl](2-iodophenyl)methanone (also known as AM-694) | | (44) | (2-Iodo-5-nitrophenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone (also known as AM-1241) | | (45) | (2-Iodophenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone (also known as AM-2233) | | (46) | (2-Iodophenyl)(1-pentyl-1H-indol-3-yl)methanone (also known as AM‑679) | | (47) | (4-Methoxyphenyl){2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone (also known as pravadoline) | | (48) | (4-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone (also known as RCS-4) | | (49) | 1-Adamantyl{1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone (also known as AM-1248) | | (50) | 1-Adamantyl(1-pentyl-1H-indol-3-yl)methanone (also known as AB‑001) | | (51) | (1-(Pent-4-en-1-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (also known as XLR-11 N-(4-pentenyl) analogue or UR-144 N-(4-pentenyl) analogue) [S 440/2022 wef 01/06/2022] |
|
21. Any compound structurally derived from indole-3-carboxamide or indole-2-carboxamide by substitution —| (a) | at the nitrogen atom of the indole ring with a type A substituent; and | | (b) | at any hydrogen atom of the carboxamide with a type B substituent, |
| whether or not the compound is further modified in any of the following ways: |
| (c) | substitution of the indole ring with a nitrogen heterocyclic analog; | | (d) | substitution to the indole ring or its nitrogen heterocyclic analog to any extent; | | (e) | substitution to the type B substituent to any extent, |
| including any salt or stereoisomeric form of the compound or derivative of the compound, any preparation or product containing the compound or derivative of the compound, and the following examples of such a compound or derivative: |
| (1) | N-(1-Adamantyl)-1-(5-bromopentyl)-1H-indazole-3-carboxamide (also known as 5-Bromo-APINACA or 5-Bromo-AKB48) | | (2) | N-(1-Adamantyl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide (also known as 5-Chloro-APINACA or 5-Chloro-AKB48) | | (3) | N-(1-Adamantyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as Adamantyl CHMINACA or SGT-37) | | (4) | N-(1-Adamantyl)-1-(5-hydroxypentyl)-1H-indazole-3-carboxamide | | (5) | N-(1-Adamantyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (also known as FUB-APINACA or FUB-AKB48) | | (5A) | N-(1-Adamantyl)-1-(4-fluorobutyl)-1H-indazole-3-carboxamide (also known as 4‑Fluoro‑ABUTINACA or 4F‑ABUTINACA or 4‑Fluoro ABINACA) | | (6) | N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-APINACA or 5F-AKB48) | | (7) | N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (also known as 5-Fluoro-APICA or STS-135) | | (7A) | N-(1-Adamantyl)-4-hydroxybutyl-1H-indazole-3-carboxamide | | (8) | N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (also known as APINACA) | | (9) | N-(1-Adamantyl)-1-pentyl-1H-indole-3-carboxamide (also known as APICA) | | (10) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as MAB-CHMINACA or ADB-CHMINACA) | | (11) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (also known as N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide or ADB-FUBINACA) | | (12) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-ADB-PINACA) | | (13) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (also known as 5-Fluoro-ADBICA) | | (14) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as ADB-PINACA) | | (15) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide (also known as ADBICA) | | (15A) | 4-{3-[(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl]-1H-indazole-1-yl}butanoic acid | | (16) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide (also known as 5-Chloro-AB-PINACA) | | (17) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as AB-CHMINACA) | | (18) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (also known as N-[1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide or AB-FUBINACA) | | (19) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide (also known as AB-FUBICA) | | (20) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-AB-PINACA) | | (21) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as AB-PINACA) | | (22) | N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as PX-3 or APP-CHMINACA) | | (23) | N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as PX-2 or 5-Fluoro-APP-PINACA) | | (24) | N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (also known as PX-1 or 5-Fluoro-APP-PICA) | | (25) | Ethyl 2-[1-(4-fluorobenzyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as EMB-FUBINACA or AEB-FUBINACA or FUB-AEB) | | (26) | Ethyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (also known as 5-Fluoro-EDMB-PINACA) | | (27) | Ethyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as 5-Fluoro-AEB or 5-Fluoro-EMB-PINACA) | | (28) | 2-[1-(4-Fluorobenzyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid | | (29) | 2-[1-(4-Fluorobenzyl)-1H-indazole-3-carboxamido]-3-methylbutanoic acid | | (30) | 2-[1-(4-Fluorobenzyl)-1H-indole-3-carboxamido]-3-methylbutanoic acid | | (31) | 2-[1-(4-Fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid | | (31A) | 2-[1-(4-Fluorobutyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoic acid | | (32) | 5-Fluoropent-1-yl-N-naphthalen-1-yl-1H-indole-3-carboxamide (also known as CBM-2201, 5-Fluoro-NNEI, 5F-NNEI or MN-24F) | | (33) | 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide (also known as 5-Fluoro-cumyl-PICA) | | (34) | 2-[1-(5-Fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid | | (35) | 2-[1-(5-Fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoic acid | | (36) | 2-[1-(5-Fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoic acid | | (36AA) | 2-[1-(5-Fluoropentyl)-1H-indole-3-carboxamido]-3-methylbutanoic acid [S 440/2022 wef 01/06/2022] | | (36A) | 2-[1-(5-Fluoropentyl)-1H-indole-3-carboxamido]-3-phenylpropanoic acid | | (36B) | 1-(5-Hydroxypentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | | (37) | Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (also known as MDMB-CHMINACA) | | (38) | Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as MA-CHMINACA) | | (39) | Methyl 2-[1-(cyclohexylmethyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate (also known as Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate or MDMB-CHMICA) | | (40) | Methyl 2-[1-(cyclohexylmethyl)-1H-indole-3-carboxamido]-3-methylbutanoate (also known as MMB-CHMICA) | | (41) | Methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate (also known as MDMB-4en-PINACA or MDMB-PINACA N1-pentyl-4-en isomer or MDMB(N)-022) | | (42) | Methyl 2-[1-(4-fluorobenzyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (also known as MDMB-FUBINACA) | | (43) | Methyl 2-[1-(4-fluorobenzyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate or MMB-FUBINACA or AMB-FUBINACA or FUB‑AMB) | | (44) | Methyl 2-[1-(4-fluorobenzyl)-1H-indole-3-carboxamido]-3-methylbutanoate (also known as MMB-FUBICA or AMB-FUBICA) | | (45) | Methyl 2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (also known as Methyl 2-{[1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate, 4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4-Fluoro-MDMB-BINACA) | | (46) | Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (also known as 5-Fluoro-MDMB-PINACA or 5‑Fluoro-ADB) | | (47) | Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as Methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate, 5F-AMP, 5-Fluoro-AMP, 5F-MMB-PINACA, 5F-AMB-PINACA, 5-Fluoro-AMB or 5‑Fluoro-MMB-PINACA) | | (48) | Methyl 2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate (also known as Methyl 2-{[1-(5-fluoropentyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate, 5F-MDMB-PICA, 5F-MDMB-2201, 5-Fluoro-MDMB-2201 or 5-Fluoro-MDMB-PICA) | | (49) | Methyl 2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3-phenylpropanoate (also known as 5-Fluoro-MPP-PICA or 5-Fluoro-MPhP-PICA or MPHP-2201) | | (50) | Methyl 2-[1-(4-hydroxybutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate | | (51) | Methyl 2-[1-(5-hydroxypentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate | | (51A) | Methyl 2-[1-(5-hydroxypentyl)-1H-indole-3-carboxamido]-3-phenylpropanoate | | (52) | N-(1-Methyl-1-phenylethyl)-1-(4-cyanobutyl)-1H-indazole-3-carboxamide (also known as 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide or Cumyl-4CN-BINACA or 4-Cyano cumyl-butinaca or SGT-78) | | (53) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (also known as 2-[(1-Butyl-1H-indazol-3-yl)formamido]-3,3-dimethylbutanamide or ADB-BUTINACA) | | (54) | 1-Pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide (also known as Cumyl-PICA) | | (54A) | 4-{3-[(1-Adamantyl)carbamoyl]-1H-indazole-1-yl}butanoic acid [S 440/2022 wef 01/06/2022] | | (55) | 5-{3-[(1-Adamantyl)carbamoyl]-1H-indazole-1-yl}pentanoic acid | | (56) | 5-{3-[(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl]-1H-indazole-1-yl}pentanoic acid | | (57) | 5-{3-[(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl]-1H-indole-1-yl}pentanoic acid | | (58) | 5-{3-[(1-Amino-3-methyl-1-oxobutan-2-yl)carbamoyl]-1H-indazole-1-yl}pentanoic acid | | (59) | 4-{3-[(2-Phenylpropan-2-yl)carbamoyl]-1H-indazole-1-yl}butanoic acid | | (60) | 2-[1-(Pent-4-en-1-yl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid | | (61) | 2-[1-(4,5-Dihydroxypentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid | | (62) | 2-(1-Butyl-1H-indazole-3-carboxamido)-3,3-dimethylbutanoic acid | | (63) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-hydroxybutyl)-1H-indazole-3-carboxamide | | (64) | 5-{3-[(2-Phenylpropan-2-yl)carbamoyl]-1H-indol-1-yl}pentanoic acid | | (65) | 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-cumyl-PINACA) | | (66) | Ethyl 2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3-methylbutanoate (also known as 5-Fluoro-EMB-PICA or EMB-2201) | | (67) | Methyl 2-[1-(4-fluorobutyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate (also known as Methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate, 4F-MDMB-BICA, 4F-MDMB-BUTICA or 4-Fluoro-MDMB-BUTICA) |
|
22. Any compound structurally derived from indole-3-carboxylic acid or indole-2-carboxylic acid by substitution —| (a) | at the nitrogen atom of the indole ring with a type A substituent; and | | (b) | at the hydrogen atom of the carboxylic acid with a type B substituent, |
| whether or not the compound is further modified in any of the following ways: |
| (c) | substitution of the indole ring with a nitrogen heterocyclic analog; | | (d) | substitution to the indole ring or its nitrogen heterocyclic analog to any extent; | | (e) | substitution to the type B substituent to any extent, |
| including any salt or stereoisomeric form of the compound or derivative of the compound, any preparation or product containing the compound or derivative of the compound, and the following examples of such a compound or derivative: |
| (1) | Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate (also known as 5-Fluoro-SDB-005) | | (2) | Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (also known as NM-2201 or CBL-2201) | | (3) | Naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate (also known as SDB-005) | | (4) | Quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate (also known as BB-22 or QUCHIC) | | (5) | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (also known as 5-Fluoro-PB-22 or 5-Fluoro-QUPIC) | | (6) | Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (also known as PB‑22 or QUPIC) |
|
|
